MarketAnalysisMarketAnalysis
NYSE:ABT

Abbott Laboratories - NYSE:ABT - Comprehensive analysis

Free evaluation through quantitative algorithms Abbott Laboratories - NYSE:ABT

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

4.59

Market

53

Sector

60

Gross Profit Growth Over Prior Year

5.03

Market

55

Sector

63

EBITDA Growth Over Prior Year

2.4

Market

47

Sector

58

EBITA Growth Over Prior Year

2.05

Market

51

Sector

56

EBIT Growth Over Prior Year

3.82

Market

55

Sector

56

Earnings from Cont. Ops. Growth Over Prior Year

135

Market

98

Sector

100

Net Income Growth Over Prior Year

135

Market

98

Sector

100

Normalized Net Income Growth Over Prior Year

3.43

Market

51

Sector

53

Diluted EPS before Extra Growth Over Prior Year

135

Market

98

Sector

100

A/R Growth Over Prior Year

5.48

Market

52

Sector

59

Inventory Growth Over Prior Year

-5.72

Market

9

Sector

15

PPE Net Growth Over Prior Year

4.05

Market

64

Sector

60

Total Assets Growth Over Prior Year

11.2

Market

85

Sector

74

Tangible Book Value Growth Over Prior Year

194

Market

100

Sector

96

Common Equity Growth Over Prior Year

23.5

Market

89

Sector

74

Cash from Ops. Growth Over Prior Year

17.86

Market

79

Sector

63

CAPEX Growth Over Prior Year

0.23

Market

52

Sector

63

Dividend per Share Growth Over Prior Year

7.69

Market

59

Sector

96

Levered Free Cash Flow Growth Over Prior Year

12.41

Market

66

Sector

75

Unlevered Free Cash Flow Growth Over Prior Year

10.59

Market

63

Sector

77

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

56

Market

70

Sector

68

SG&A Margin %

26.5

Market

59

Sector

49

EBITDA Margin %

25.5

Market

64

Sector

82

EBITA Margin %

22.3

Market

64

Sector

82

EBIT Margin %

17.87

Market

56

Sector

86

Earnings from Cont. Ops Margin %

31.9

Market

94

Sector

100

Net Income Margin %

31.9

Market

93

Sector

100

Net Income Avail. for Common Margin %

31.8

Market

95

Sector

100

Normalized Net Income Margin %

10.64

Market

48

Sector

90

Levered Free Cash Flow Margin %

13.37

Market

61

Sector

90

Unlevered Free Cash Flow Margin %

14.21

Market

61

Sector

90

Return on Assets %

6.06

Market

54

Sector

83

Return on Capital %

7.95

Market

32

Sector

82

Return on Equity %

30.9

Market

76

Sector

89

Return on Common Equity %

31

Market

75

Sector

93

Total Asset Turnover

0.54

Market

42

Sector

75

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 30
Momentum: 82
Growth: 66
Profitability: 65

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

5.73

Market

70

Sector

66

TEV/LTM EBITDA

21.3

Market

83

Sector

75

P/LTM Normalized EPS

51

Market

83

Sector

80

P/BV

4.83

Market

63

Sector

76

TEV/LTM Unlevered FCF

38.1

Market

77

Sector

74

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

5.49

Market

83

Sector

54

3M Price Performance

7.53

Market

73

Sector

71

6M Price Performance

18.58

Market

91

Sector

85

9M Price Performance

18.02

Market

79

Sector

80

1Y Price Performance

30.1

Market

82

Sector

85

Start analyzing Abbott Laboratories - NYSE:ABT with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports